Blood and urine analyses were conducted on pregnant and non-pregnant subjects who had each received 50 mg promazine intravenously. A typical exponential fall in the concentration of promazine in blood was observed. The obstetric patients were found to excrete, in a 24-hour sample of urine, considerably more promazine (and its primary metabolites) than did the non-obstetric subjects. Two neonates, who were given promazine intramuscularly, resembled the obstetric patients in the latter regard. Promazine could be identified in cord blood 2 minutes after intravenous administration to the mother, and a maximum level of concentration was reached 2-3 minutes later. Allowing for the influence of a "time-lag", concentration in foetal blood was always lower than that in maternal blood. Results of the urine analyses suggested that approximately 0.5 per cent of the amount of promazine given intravenously to the mother reaches the foetus. A small amount of promazine is retained by placental tissue.
The important factors which govern the selection of drugs for placental transmission are now well known (Moya and Kvisselgaard, 1961) . However, although appreciation of these general principles is mandatory to the intelligent care of a patient in labour, understanding of the precise dynamics of transference of the individual drugs in common use should add considerably to the ability of the clinician to anticipate more closely the results of the therapy which he initiates. The phenothiazine derivatives provide a case in point, for there remains the need to demonstrate the speed and extent of placental transference of these commonly used drugs.
Investigation of the placental passage of phenothiazines has been hindered by the fact that it is difficult to assay the drugs quantitively in biological fluids. The restriction on the use of radioactive isotopes in this field has compounded the difficulty. Partly in consequence of this, the initial investigations in the field, conducted shortly after the phenothiazines were introduced into clinical practice, were confined to examination of the urine of infants whose mothers had received the drug during labour. Lacomme and Le Lorier (1955) identified a small quantity of chlorpromazine in the urine of such infants, but could discover no relationship between the quantity recovered and either the dose administered or the time which had elapsed between administration of the drug and the delivery of the infant. Behn, Frahm and Fretwurst (1956) gave two patients an equal mixture of chlorpromazine and promethazine: 50 mg of the mixture was injected intramuscularly (30 minutes and 120 minutes predelivery respectively), and 33 mg of the mixture was given intravenously (17 minutes and 25 minutes pre-delivery respectively). Behn, Frahm and Fretwurst studied, by a method of paper chromatography, the urine subsequently passed by each infant, and they concluded, on the basis of their findings, that 0.5-1.0 per cent of the dosage given to the mother had been passed to the foetus, and that the drug was completely excreted by the infant within 48-60 hours of delivery.
Later, in a brief communication, Adelman and his colleagues (1958) claimed to have demonstrated that promethazine did not cross the placental barrier. There is good reason to suppose, however, that there is considerable error inherent in the method of analysis used by these workers (a method which was used subsequently both by Potts and Ullery (1961) and by one of us (Crawford, 1960) in obtaining results which suggested that the drug could be identified in foetal blood).
Recently, Wiser, Knebel and Seifter (1960) have described a new method of analysis, and it is the application of this which has provided us with the data presented here.
Promazine.
METHODS

Laboratory.
The method described by Wiser, Knebel and Seifter (1960) involves the spectrophotometric analysis of a colour obtained by treating, with arsenic pentoxide and hydrochloric acid, the phenothiazine which has been extracted from the biological fluid by heptane. We applied this method to the analysis of specimens of blood and urine.
Metabolites. Walkenstein and Seifter (1959) have drawn attention to the fact that the major identifiable metabolites of phenothiazine to be found in the urine are the sulphoxide, the monomethyl compound, and the monomethyl sulphoxide. Wiser and his colleagues (1960) suggest that it is possible to measure the concentration of the former two metabolites in combination. We analyzed samples of maternal and neonatal urine in this way, and suggest that the results give a good measure of the total quantity of degradation products of promazine excreted by the individual during the time when urine was being collected.
Placenta.
Three placentae were obtained for analysis, two from patients who had each received promazine 50 mg intravenously, the third being used to provide a standard curve. The organs were freed from blood by flushing with potassium oxalate solution, and then the membranes were dissected away. The placental tissue was mashed, dried, ground and weighed. The ground tissue was shaken in a mixture of 10 ml phosphate buffer (pH 6.7) and 100 ml n-heptane, for 8 hours. The heptane layer was removed and the process repeated twice more. The three aliquots of heptane were pooled and, by using the material obtained from the "blank" placenta for standards, the quantity of promazine and of major metabolites BRITISH JOURNAL OF ANAESTHESIA in the other two specimens was ascertained. In order to be sure that extraction had been complete, the placental residues from each case were again washed three times with heptane, and the pooled extracts treated in the manner outlined above.
Clinical. An initial study was made on twelve non-obstetric patients, each of whom was given promazine 50 mg (made up in 5--6 ml in water) intravenously, after a "blank" specimen of blood and of urine had been obtained. Blood was subsequently drawn at 1-2, 5, 10, 20 and 60 minutes after completion of the injection (the late samples were not drawn in all cases), and a 24-hour sample of urine was obtained.
The co-operation of these patients was sought, with the approval of their respective surgeons, during the first week following a relatively minor operation. When the nature of the procedure was explained to them, and its relevance to the study here being reported, they willingly, and in some cases eagerly, agreed to offer themselves as subjects.
The same quantity of promazine, administered in similar fashion, was given to twenty-four patients shortly before delivery. A sample of maternal blood was drawn at the time of delivery in twenty-two of these cases, and in all twentyfour cases, immediately after delivery, blood for analysis was obtained from the umbilical vein. The urine passed by mother and infant during the 24 hours subsequent to delivery was collected.
None of the thirty-six patients mentioned above had received a phenothiazine derivative during the 2-3 days prior to the investigation.
Two neonates, whose mothers had not been given a phenothiazine derivative during labour, received promazine by intramuscular injection after a "blank" sample of urine had been obtained from them. The urine which each infant passed during the subsequent and successive two periods of 24 hours was collected for analysis.
The study was discussed fully with the paediatrician in charge of the nursery, and with the Chief of Anaesthesia long before it was undertaken. The particular infants were chosen in consultation with the paediatrician in charge of the nursery. The assent of the two mothers was obtained, after it had been explained to them that their infants would be given approximately as much promazine as each would have received via the placenta if the mother had had the drug during labour, and that the objective was an increase in our knowledge of the range of safety in obstetric practice.
Statistical.
In every case, a standard curve was constructed by using blood and urine obtained from the adult patient prior to the administration of the drug. The curves were obtained from the analyses of samples containing the following known concentrations of promazine: 2.5 [J-g, 5 [J-g and 10 [J-g per 2 ml of biological fluid, and a blank specimen. Each analysis was conducted in duplicate and the individual samples from each set were read in randomized order.
Maternal and cord blood samples were obtained from six cases in which promazine had not been administered. The samples were subjected, in duplicate, to the analytical technique, and the optical density readings are presented in table I. We thus had eighteen dependent variables (six sets with four replicates within each set). By applying to our results (table I) the method of 0.7 analysis suggested by Dixon and Massey (1957) , we were able to determine that, if the mean of the optical density readings of a pair of unknowns differs by 0.004 or more from the mean of the duplicate blanks, it may be presumed that promazine is present in the unknown sample. two occasions. Computation of these results yielded a mean standard line of 0.123 optical density units per 10 !Jog of promazine in 2 m1 blood (standard deviation 0.016; 95 per cent confidence limits 0.118 and 0.128); that is, an increased optical density reading of 0.012 over the blank reading was indicative of the presence of 1 !Jog of promazine per 2 ml of blood. As explained above, we could place confidence in a difference of 0.004 optical density which, interpreted on the standard line, is 0.33 !Jog per 2 m1 of blood, or 0.16 !Jog of promazine per ml of blood.
RESULTS
Blood.
Applying the criteria of recognition indicated under "Laboratory Methods", it may be said that in eleven of the twelve non-obstetric cases we identified the presence of promazine in the blood drawn 1-2 minutes after administration of the drug. Promazine was identified in five of the eleven samples drawn 5 minutes after injection; in five of the ten 1O-minute samples; in one of the seven 20-minute samples; and in one of the five samples taken 60 minutes after injection.
We have constructed a graph depicting the change of level of concentration with increasing time following injection ( fig. 1) , by computing the means of the differences between the optical density readings of the charged samples and those of the appropriate blanks, and translating these into terms of concentration by use of the standard curve. Figure 1 reveals the familiar exponential-type curve, but it must be emphasized that numerical significance can be attached only to the initial (2-minute) mean concentration.
The results of analyses of maternal blood have been plotted individually in figure 1 , and it will be seen that they fit the mean non-obstetric curve fairly well. The differences between the mean of the optical density readings obtained from the blanks (the pre-injection samples of blood) and the optical density readings obtained from the cord blood, interpreted in terms of concentration of promazine in blood, have been plotted against the time between administration of the drug and delivery of the infant (fig. 2) .
The metabolic breakdown products of promazine were sought for in several of the blood samples, but the results were inconclusive. Urine. Promazine and two of its three major metabolic breakdown products (referred to as sulphoxides) were identified in almost all of the samples of urine obtained from the adult subjects (table II) . (g) (mg) (ml) (J.'g/ml) (J.'g) (J.'g/ml) (J.'g) (ml) (,'g/ml) (J.'g) (J.'g/ml) The data concerning the two neonates who received an intramuscular injection of promazine are presented in table IV.
TABLE V Results of analyses of two placentae (A and B) from which blood had been flushed prior to drying. The mothers had been given promazine 50 mg intravenously prior to delivery (interval noted as I-D). Figures in brackets indicate amount of material extracted at first and second washings
It was found to be difficult to collect the entire 24-hour specimen of urine from the female infants, so data referable to the male infants only will be included here. There were sixteen such infants and in most of these cases promazine and the sulphoxides were identified in the urine (table III) .
Placentae.
The placentae obtained from two patients who had received 50 mg promazine intravenously were found to contain both promazine and "sulphoxide" (table V) .
DISCUSSION
The results presented here strongly confirm the opinion (Lacomme and Le Lorier, 1955; Behn, Frahm and Fretwurst, 1956 ) that promazine may be transmitted from mother to foetus. Passage through the placenta starts within 1-3 minutes following the intravenous administration of a concentrated dose of the drug (50 mg in 5-6 ml). The maximum concentration in cord blood is achieved probably within 2 minutes of the start of transmission (that is, about 4 minutes after administration of the drug), and thereafter the level of foetal blood concentration falls in the familiar exponential fashion. If allowance is made for the lag induced by the dynamics of placental transfer, it may be said that the concentration of the drug in foetal blood is never higher than that found in maternal blood at any time of sampling, but during the period between 4 and 8 minutes following injection, the levels may possibly be close to equal. However, it must be emphasized that a reliable identification of promazine in the cord blood was made on only a few occasions, and that much of the data presented in table II is highly speculative.
As indicated in table II, the obstetric patients excreted in their urine, as a combined total of promazine and of two of the three primary meta·· bolites, 4.7 per cent of the administered dose during the 24 hours subsequent to the injection. We are unable categorically to account for the fact that both the concentration of the products in urine and the total urinary excretion were BRITISH JOURNAL OF ANAESTHESIA smaller among the non-obstetric patients. However, observations conducted on the neonates (table IV) suggest that the capacity of the infant in this regard is at least equal to that of the nonpregnant adult. It may be assumed, on the basis of the latter findings, that the infant will, during the 24 hours subsequent to delivery, excrete (as promazine plus "sulphoxides") approximately 3.5 per cent of the total amount of promazine which it received via the placenta. If now we consider the cases referred to in table II, and exclude the case in which delivery occurred within a few seconds of the administration of promazine, we see that the mean total excretion of promazine plus "sulphoxides" was 7.5 [Lg. Thus it may be deduced that during the first 1-16 minutes (mean 8.2 minutes) following the intravenous administration of promazine 50 mg in concentrated form to the mother, approximately 210 [Lg reaches the infant-or, in other words, 0.4 per cent of a dose so administered is transmitted via the placenta. This deduction is in good accord with the suggestion made by Behn, Frahm and Fretwurst (1956) .
Placenta.
The amount of promazine, as a combination of the unchanged compound and its primary metabolites, which could be extracted from the placentae, suggests that the accumulation of the drug in the placenta is no greater than that to be expected from general distribution of the drug throughout the body. In this respect, placental tissue may be distinguished from lung, kidney, spleen and brain (Fyodorov, 1958) . Further, a distinction may be drawn between promazine and morphine as the latter is apparently very poorly retained by the placenta (Shute and Davis, 1933) .
The results suggest that placental tissue retains a certain proportion of the promazine which is carried in maternal blood to the placental site, thus diminishing the unit amount available for transfer from maternal to foetal circulation. Possibly the proportion of promazine so captured by placental tissue is dependent upon the level of concentration of drug in maternal blood.
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